Medication info

Evatoreum Tablet 10/20

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Aprogen Biologics Co., Ltd.
Appearance
White to off-white, biconvex, rectangular tablet
Packaging
30 tablets/Alu-Alu packaging (10 tablets/Alu-Alu x 3)
Approval status
Active

MFDS item code 201603654 · Approved 2016.06.21

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking serum lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with abnormal liver function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine with caution in these patients and monitor them carefully (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use) Administer this medicine at least 2 hours before or 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone must not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine must not exceed 10/20mg/day of this medicine.

Ingredients

Manufacturer
Aprogen Biologics Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • elevated total cholesterol
  • LDL cholesterol
  • Apo B
  • triglycerides
  • homozygous familial hypercholesterolemia
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication is used as an adjunct to diet for the reduction of elevated total cholesterol, LDL cholesterol, Apo B, and triglyceride levels in patients with primary hypercholesterolemia and mixed hyperlipidemia, and to increase HDL cholesterol levels. It is also used in patients with homozygous familial hypercholesterolemia when other treatments are ineffective or as adjunctive treatment. It should be used in conjunction with appropriate dietary measures, such as restricting saturated fat and cholesterol intake, and consider the overall risk factors of the patient according to hyperlipidemia treatment guidelines. It is also important to check for other causes of dyslipidemia and treat them if necessary. This medication improves the risk of hypercholesterolemia and associated atherosclerotic vascular disease by controlling total cholesterol, LDL, HDL, and triglyceride levels.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg once daily. The generally recommended initial dose is 10/20mg once daily. For patients who require less LDL cholesterol reduction, treatment may be started at 10/10mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking serum lipid levels at intervals of 4 weeks or longer. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with abnormal liver function under Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20mg of this medicine once daily in the evening. Use higher doses of this medicine with caution in these patients and monitor them carefully (see 5. General Precautions under Precautions for Use). Administration to older adults No dose adjustment is necessary in older adults. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use) Administer this medicine at least 2 hours before or 4 hours after a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone must not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine must not exceed 10/20mg/day of this medicine.

Precautions

This medication is used to lower blood cholesterol levels. Caution should be exercised as symptoms such as muscle pain or weakness may occur while taking this medication. Particularly, if there are severe muscle pain or weakness symptoms, the doctor should be informed immediately. This medication may affect liver function, so it should not be taken if there is liver disease or abnormally high liver enzyme levels. Women who are pregnant or breastfeeding should not take this medication, and women who are planning to become pregnant should consult a doctor before taking it. Additionally, this medication may pose an increased risk of muscle damage when taken with certain antifungals, antibiotics, immunosuppressants, etc., so patients should inform their doctor of any other medications being taken. Special caution is required for elderly patients or those with impaired kidney function. It is advisable to undergo regular blood tests during the course of treatment to monitor liver function and muscle status. In case of overdose, there is no specific antidote, and appropriate treatment will be provided according to symptoms. Finally, it is safe to avoid grapefruit juice or certain medications during the course of treatment with this medication.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory tract infection
  • myalgia
  • limb pain
  • fatigue
Show 93 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • increased liver amino transferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • myasthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • disturbances of ocular motility
  • facial weakness
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • psychiatric disorders
  • anxiety
  • sleep disorders
  • cognitive decline
  • amnesia
  • memory loss
  • memory impairment
  • confusion
  • interstitial lung disease
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • arthritis
  • photosensitivity
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • alopecia
  • various skin changes
  • drug-induced lichenoid eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ophthalmoplegia
  • anemia
  • elevated amino transferases
  • increased ALP
  • elevated ɤ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function tests
  • increased HbA1c
  • elevated fasting blood glucose levels
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to store it at room temperature, between 1 degrees and 30 degrees Celsius. This helps maintain the potency of the medication and prevents degradation.

Appearance and packaging

Appearance

White to off-white, biconvex, rectangular tablet

Package unit

30 tablets/Alu-Alu packaging (10 tablets/Alu-Alu x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.